glp-1 dementia How GLP-1s Could Transform Alzheimer's Treatment Interest in using GLP-1 medications

There are many things that can go wrong, she said

The liver benefits require attention, particularly for patients with fatty liver disease

These drugs bind to the GLP-1 receptor and: Lower blood sugar by increasing insulin and reducing glucagon Slow gastric emptying Reduce appetite and food cravings Support clinically significant weight loss in many people They are commonly prescribed for: Type 2 diabetes Obesity or overweight with weight-related health risks Trials suggest GLP-1 agonists can reduce body weight by around 5 to 18 per cent on average, often with improvements in blood pressure, cholesterol and other cardiometabolic markers

However, several factors influenced the results as patients were also predisposed to many factors that increase the risk of kidney injury, such as non-steroidal anti-inflammatory drugs use, hypertension, urinary tract infections, and other factors[53]

The relevance of these findings to humans is unknown

Maddox says